NCT00995475View on ClinicalTrials.gov

A Proof of Concept Study to Evaluate the Dose Response for the Systemic Benefit Risk Ratio of Inhaled Fluticasone Propionate in Chronic Obstructive Pulmonary Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
COPD
Interventions
DRUG

Fluticasone propionate

DRUG

Placebo

All Listed Sponsors
lead

University of Dundee

OTHER

NCT00995475 - A Proof of Concept Study to Evaluate the Dose Response for the Systemic Benefit Risk Ratio of Inhaled Fluticasone Propionate in Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter